In a 2025 Aging Cell study, researchers under Dr. Vadim Gladyshev demonstrated that elamipretide, administered via osmotic pumps in Black 6 mice, reduced frailty and enhanced cardiac performance. This intervention underscores the potential of mitochondrial therapies for age-related conditions.